Drug intelligence / Profile preview

duanjin jiedu

Development stage
Unknown
Lead developer
Yunnan Mingjing Henry Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Duanjin Jiedu is a Traditional Chinese Medicine (TCM) formulation developed by Yunnan Mingjing Henry Pharmaceutical for the treatment of opioid use disorder and the management of withdrawal symptoms. It is primarily used to alleviate the physical and psychological distress associated with heroin or opium cessation. The formulation typically consists of multiple botanical ingredients, including *Corydalis yanhusuo* and *Aconitum carmichaelii*, which work synergistically to modulate the central nervous system. It is thought to exert its therapeutic effects by interacting with the Mu-type opioid receptor and modulating the dopaminergic system, thereby reducing cravings and physical dependence. It has been approved and marketed in China as a non-addictive alternative for detoxification.

Brand names
Duanjin Jiedu
Other names
Duanjin Jiedu CapsulesDuanjin Jiedu Jiaonang
02

Targets

DRD (Dopamine receptors)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on duanjin jiedu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on duanjin jiedu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call